Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial to Assess Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI Outcomes in Infertile Women Presenting With Adenomyosis.

NCT03940807 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03940807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial to Assess Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI Outcomes in Infertile Women Presenting With Adenomyosis.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Withdrawn
Start date
April 29, 2022
Completion date
January 31, 2025
Enrollment
0 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

adenomyosis